SARS-CoV-2 nsp16 受到宿主 E3 泛素连接酶,UBR5 和 MARCHF7 的调节
Li Tian1, Zongzheng Zhao2, Wenying Gao1
1Department of Infectious Diseases, Infectious Diseases and Pathogen Biology Center, Institute of Virology and AIDS Research, Key Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, The First Hospital of Jilin University, Changchun, China.
eLife
|May 13, 2025
概括
主体E3链酶UBR5和MARCHF7向SARS-CoV-2nsp16蛋白进行降解,抑制病毒复制. 这一发现揭示了COVID-19治疗的新治疗点.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 导致COVID-19,这是全球卫生危机.
- 病毒nsp16蛋白质对于病毒mRNA限制至关重要,有助于SARS-CoV-2逃避宿主免疫力.
- 对于nsp16的宿主因子调节的了解仍然很少,这限制了治疗策略.
研究的目的:
- 调查宿主E3泛素酶在调节SARS-CoV-2nsp16.16中的作用.
- 为了确定针对nsp16进行蛋白质体降解的特定E3链酶.
- 探索这些链酶作为针对SARS-CoV-2的治疗点的潜力.
主要方法:
- 研究了nsp16.16的无处化和蛋白质体降解.
- 利用细胞培养和小鼠模型来评估抗病毒活性.
- 检查了通过已识别的E3链酶介导的泛化类型 (K48链接和K27链接).
主要成果:
- 证明了宿主E3链酶UBR5和MARCHF7调解NSP16的泛化和蛋白质体降解.
- 表明UBR5诱导了K48链接的无所不在,而MARCHF7促进了K27链接的无所不在.
- 证实UBR5和MARCHF7在体外和体内抑制SARS-CoV-2的复制,对不同的病毒菌株表现出广泛的活性.
结论:
- 确定了UBR5和MARCHF7作为调节nsp16稳定性和功能的关键宿主因素.
- 揭示了新型抗病毒机制,其中涉及针对SARS-CoV-2的全方位蛋白酶系统.
- 强调UBR5和MARCHF7是开发广泛的COVID-19治疗的有希望的治疗标.
相关概念视频
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Regulation of Nuclear Protein Sorting
2.3K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.3K
Regulation of the Unfolded Protein Response
2.3K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.3K
Regulated Protein Degradation
7.1K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.1K
Regulation of Expression at Multiple Steps
850
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
850
The Unfolded Protein Response
4.3K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.3K


